SOPHiA GENETICS Stock – A Play on Data Driven Medicine

When artificial intelligence (AI) algorithms are able to predict how proteins fold based on amino acid sequences, it makes one wonder why it’s taking so long to move from spray-and-pray medicine to data-driven medicine. Today’s AI algorithms are certainly sophisticated enough, and there’s plenty of delicious big data to be found. The problem lies in aggregating the data from all the disparate silos where it currently lives. One company looking to start mankind down the path toward data-driven precision medicine is SOPHiA GENETICS (SOPH).

About SOPHiA GENETICS Stock

We first came across SOPHiA GENETICS several years back in a piece on The Top-10 Artificial Intelligence Startups in Switzerland, and then again in our piece on